In this study, we conducted an analysis of snRNA-seq data from a cohort of patients treated with anti-PD-1 therapy, revealing the presence of heterogeneity in tumor cells, lymphocytes, myeloid cells, and stromal cells. This evidence concerns the gene PDCD1 and neoplasm.